Stay updated on ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer

Sign up to get notified when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.
Latest website image capture
Clouds background image

Latest updates to the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-04-29T12:24:48.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The page has undergone significant changes, including the removal of detailed study descriptions and inclusion criteria for a Phase 3 clinical trial on ovarian cancer, while adding new identifiers and a revision number.
    Difference
    7%
    Check dated 2025-04-22T04:17:11.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to January 17, 2025.
    Difference
    0.2%
    Check dated 2025-04-07T15:04:51.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new last update date of March 25, 2025, and a revision change to v2.14.3.
    Difference
    0.2%
    Check dated 2025-03-31T11:21:37.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.8%
    Check dated 2025-02-23T12:52:42.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new version, v2.14.2, and includes a notice about heavy traffic affecting some NLM-NCBI services and products.
    Difference
    0.8%
    Check dated 2025-02-09T07:41:46.000Z thumbnail image

Stay in the know with updates to ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer

Enter your email address, and we'll notify you when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.